Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

737 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The influence of HLA-matched sibling donor availability on treatment outcome for patients with AML: an analysis of the AML 8A study of the EORTC Leukaemia Cooperative Group and GIMEMA. European Organization for Research and Treatment of Cancer. Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto.
Keating S, de Witte T, Suciu S, Willemze R, Hayat M, Labar B, Resegotti L, Ferrini PR, Caronia F, Dardenne M, Solbu G, Petti MC, Vegna ML, Mandelli F, Zittoun RA. Keating S, et al. Br J Haematol. 1998 Sep;102(5):1344-53. doi: 10.1111/j.1365-2141.1998.896hm3674.x. Br J Haematol. 1998. PMID: 9753069 Free article. Clinical Trial.
Prognostic factors of patients with acute myeloid leukemia (AML) allografted in first complete remission: an analysis of the EORTC-GIMEMA AML 8A trial. The European Organization for Research and Treatment of Cancer (EORTC) and the Gruppo Italiano Malattie Ematologiche Maligne dell' Adulto (GIMEMA) Leukemia Cooperative Groups.
Keating S, Suciu S, de Witte T, Mandelli F, Willemze R, Resegotti L, Broccia G, Thaler J, Labar B, Damasio E, Bizzi B, Rotoli B, Vekhoff A, Muus P, Petti MC, Dardenne M, Solbu G, Vegna ML, Zittoun RA. Keating S, et al. Bone Marrow Transplant. 1996 Jun;17(6):993-1001. Bone Marrow Transplant. 1996. PMID: 8807105 Clinical Trial.
Centre effect on treatment outcome for patients with untreated acute myelogenous leukaemia? An analysis of the AML 8A Study of the Leukemia Cooperative Group of the EORTC and GIMEMA. European Organization for Research and Treatment of Cancer (EORTC) Leukemia Cooperative Group and the Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto (GIMEMA).
Keating S, de Witte T, Suciu S, Mandelli F, Damasio E, Willemze R, Morra E, Amadori S, Dardenne M, Vegna ML, Zittoun RA. Keating S, et al. Eur J Cancer. 1999 Oct;35(10):1440-7. doi: 10.1016/s0959-8049(99)00148-3. Eur J Cancer. 1999. PMID: 10673975 Clinical Trial.
The stem cell mobilizing capacity of patients with acute myeloid leukemia in complete remission correlates with relapse risk: results of the EORTC-GIMEMA AML-10 trial.
Keating S, Suciu S, de Witte T, Zittoun R, Mandelli F, Belhabri A, Amadori S, Fibbe W, Gallo E, Fillet G, Varet B, Meloni G, Hagemeijer A, Fazi P, Solbu G, Willemze R; EORTC Leukemia Group; GIMEMA Leukemia Group. Keating S, et al. Leukemia. 2003 Jan;17(1):60-7. doi: 10.1038/sj.leu.2402782. Leukemia. 2003. PMID: 12529661 Free article. Clinical Trial.
Getting to the marrow of trained immunity.
Groh L, Netea MG, Riksen NP, Keating ST. Groh L, et al. Epigenomics. 2018 Sep;10(9):1151-1154. doi: 10.2217/epi-2018-0098. Epigenomics. 2018. PMID: 30238777 No abstract available.
β-Glucan-Induced Trained Immunity Protects against Leishmania braziliensis Infection: a Crucial Role for IL-32.
Dos Santos JC, Barroso de Figueiredo AM, Teodoro Silva MV, Cirovic B, de Bree LCJ, Damen MSMA, Moorlag SJCFM, Gomes RS, Helsen MM, Oosting M, Keating ST, Schlitzer A, Netea MG, Ribeiro-Dias F, Joosten LAB. Dos Santos JC, et al. Among authors: keating st. Cell Rep. 2019 Sep 3;28(10):2659-2672.e6. doi: 10.1016/j.celrep.2019.08.004. Cell Rep. 2019. PMID: 31484076 Free article. Clinical Trial.
An integrative genomics approach identifies KDM4 as a modulator of trained immunity.
Moorlag SJCFM, Matzaraki V, van Puffelen JH, van der Heijden C, Keating S, Groh L, Röring RJ, Bakker OB, Mourits VP, Koeken VACM, de Bree LCJ, Smeekens SP, Oosting M, Gamboa RA, Riksen NP, Xavier RJ, Wijmenga C, Kumar V, van Crevel R, Novakovic B, Joosten LAB, Li Y, Netea MG. Moorlag SJCFM, et al. Among authors: keating s. Eur J Immunol. 2022 Mar;52(3):431-446. doi: 10.1002/eji.202149577. Epub 2021 Dec 10. Eur J Immunol. 2022. PMID: 34821391 Free PMC article.
The role of Toll-like receptor 10 in modulation of trained immunity.
Mourits VP, Arts RJW, Novakovic B, Matzaraki V, de Bree LCJ, Koeken VACM, Moorlag SJCFM, van Puffelen JH, Groh L, van der Heijden CDCC, Keating ST, Netea MG, Oosting M, Joosten LAB. Mourits VP, et al. Immunology. 2020 Mar;159(3):289-297. doi: 10.1111/imm.13145. Epub 2019 Nov 26. Immunology. 2020. PMID: 31671203 Free PMC article.
Trained immunity and diabetic vascular disease.
Thiem K, Stienstra R, Riksen NP, Keating ST. Thiem K, et al. Clin Sci (Lond). 2019 Jan 18;133(2):195-203. doi: 10.1042/CS20180905. Print 2019 Jan 31. Clin Sci (Lond). 2019. PMID: 30659160 Review.
737 results